Ilumink, a fresh spin-out of the University of Cambridge, is building links with industry and raising seed financing to commercialise technology which aims to disrupt the counterfeit drug black market. The company is developing liquid crystal lasers, spun out from the university’s engineering department and funded by the Royal Academy of Engineering, which can be…
Cambridge’s Ilumink targets drug pirates
Feb 10, 2014 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024